Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOdyssean Inves. Regulatory News (OIT)

Share Price Information for Odyssean Inves. (OIT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 162.50
Bid: 162.50
Ask: 164.00
Change: 0.50 (0.31%)
Spread: 1.50 (0.923%)
Open: 163.00
High: 163.00
Low: 162.00
Prev. Close: 162.00
OIT Live PriceLast checked at -
Odyssean Investment Trust is an Investment Trust

To achieve attractive total returns per share principally through capital growth over a longterm period through investment in companies predominantly in the UK.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

23 Feb 2023 08:36

RNS Number : 8432Q
Odyssean Investment Trust PLC
23 February 2023
 

23 February 2023

 

ODYSSEAN INVESTMENT TRUST PLC

(the "Company")

 

 

Appointment of New Director

 

 

The Board of Odyssean Investment Trust PLC is pleased to announce the appointment of Neil Mahapatra as an independent, non-executive Director of the Company, with effect from Monday, 3 April 2023.

 

Mr Mahapatra is a Founder and Managing Partner of Kingsley Capital Partners LLP, a family office backed private investment firm that creates and builds businesses from inception. Through Kingsley, Mr Mahapatra has created numerous companies across different sectors, including FTSE-listed biotechnology firm Oxford Cannabinoid Technologies and UK wholesale fibre internet business Spring Fibre, which recently closed a £155m investment from the infrastructure fund of River & Mercantile plc. Neil is a Director of Oxford Cannabinoid Technologies Limited and is also Chair of the MASS Design Group, working with the two founders for over a decade to grow the organisation into one of the leading architecture & design firms in the world.

 

Previously he worked at J. Rothschild Capital Management, where he led the private investment activities for Lord Rothschild and RIT Capital Partners plc.

 

Neil began his career in investment banking at Morgan Stanley and holds a BA in Biological Sciences from Oxford University, where he was President of the Oxford Union. He also holds an MBA from the Harvard Business School, where he was a Fulbright Scholar.

 

The Chair of Odyssean Investment Trust PLC, Jane Tufnell, commented:

 

"My fellow Directors and I are delighted to welcome Neil to the Board. We are very pleased to have someone with such a breadth of investment experience joining us as a Director."

 

Mr Mahapatra appointment will be proposed to shareholders for election at the Annual General Meeting of the Company to be held in September 2023.

 

Mr Mahapatra currently holds no ordinary shares in the Company.

 

There is no further information to be disclosed under Listing Rule 9.6.13R(2) to (6).

 

 

- ENDS-

 

 

 

For further information please contact:

 

Mark Pope

Frostrow Capital LLP

020 3 008 4913

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFZGZZRFZGFZG
Date   Source Headline
3rd May 20242:03 pmRNSNet Asset Value(s)
2nd May 20242:17 pmRNSNet Asset Value(s)
1st May 20243:05 pmRNSNet Asset Value(s)
1st May 202410:11 amRNSTotal Voting Rights
30th Apr 20243:20 pmRNSNet Asset Value(s)
29th Apr 20241:25 pmRNSNet Asset Value(s)
26th Apr 20245:44 pmRNSIssue of Equity
26th Apr 20242:22 pmRNSNet Asset Value(s)
25th Apr 20244:39 pmRNSNet Asset Value(s)
24th Apr 20241:34 pmRNSNet Asset Value(s)
23rd Apr 20242:28 pmRNSNet Asset Value(s)
22nd Apr 20242:00 pmRNSNet Asset Value(s)
19th Apr 202412:57 pmRNSNet Asset Value(s)
19th Apr 20247:00 amRNSCompliance with Market Abuse Regulation
18th Apr 20243:23 pmRNSNet Asset Value(s)
17th Apr 20242:23 pmRNSNet Asset Value(s)
16th Apr 20242:48 pmRNSNet Asset Value(s)
15th Apr 20242:04 pmRNSNet Asset Value(s)
12th Apr 20242:44 pmRNSNet Asset Value(s)
11th Apr 20244:02 pmRNSMonthly Fact Sheet as at 31 March 2024
11th Apr 20242:44 pmRNSNet Asset Value(s)
10th Apr 20243:10 pmRNSNet Asset Value(s)
10th Apr 20242:52 pmRNSDirector/PDMR Shareholding
9th Apr 20242:57 pmRNSNet Asset Value(s)
8th Apr 20244:20 pmRNSIssue of Equity
8th Apr 20241:45 pmRNSNet Asset Value(s)
5th Apr 20242:37 pmRNSNet Asset Value(s)
4th Apr 20242:31 pmRNSNet Asset Value(s)
3rd Apr 20243:44 pmRNSNet Asset Value(s)
2nd Apr 20244:20 pmRNSNet Asset Value(s)
2nd Apr 202410:23 amRNSTotal Voting Rights
2nd Apr 20249:54 amRNSDirectorate Change
28th Mar 20245:57 pmRNSDirector/PDMR Shareholding
28th Mar 20241:51 pmRNSNet Asset Value(s)
27th Mar 20241:20 pmRNSNet Asset Value(s)
26th Mar 20243:34 pmRNSNet Asset Value(s)
25th Mar 20242:23 pmRNSNet Asset Value(s)
25th Mar 202410:32 amRNSDirector/PDMR Shareholding
22nd Mar 20241:54 pmRNSNet Asset Value(s)
21st Mar 20241:26 pmRNSNet Asset Value(s)
20th Mar 20245:09 pmRNSIssue of Equity
20th Mar 20241:10 pmRNSNet Asset Value(s)
19th Mar 20242:48 pmRNSNet Asset Value(s)
18th Mar 20244:34 pmRNSIssue of Equity
18th Mar 20243:09 pmRNSNet Asset Value(s)
15th Mar 20241:52 pmRNSNet Asset Value(s)
14th Mar 20241:53 pmRNSNet Asset Value(s)
13th Mar 20245:02 pmRNSIssue of Equity
13th Mar 20241:39 pmRNSNet Asset Value(s)
12th Mar 20244:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.